Melio to get EUR 600k from Beaumont Capital.

Melio, a Madrid, Spain-based developer of an online medical services platform aimed at providing medical consultancy, announced raising funding of 600,000 euro ($660k).

The money was provided by English investors including Beaumont Capital, an Oxford investment fund led by Andrew Johnson and angel investor based in UK Gi Fernando.

Melio, founded in 2019 and led by CEO Mario Cantero, developed an online platform offering blood test profiles and examines health markers such as testosterone, ApoA, ApoB, estradiol, glucose, cholesterol, PSA and iron, enabling clients to experience a different blood test schedule where they can receive the doctor's comments and view their results online within 48 hours. The company provides more than 10 blood analysis profiles and analyzes more than 100 health markers. The price per analysis varies from 19 to 140 euros.